The Albert B. Sabin Vaccine Institute, Inc.
Nonprofit global health organization focused on advancing vaccine research and development, expanding immunization programs, and supporting vaccine access, acceptance, and delivery worldwide. Activities documented include candidate vaccine development and clinical trials, applied epidemiology and vaccine effectiveness studies, CMC program management, regulatory engagement with major agencies, data dashboards for immunization insights, and delivery of investigational vaccines during outbreaks.
Industries
N/A
Products
Global Immunization Insights Dashboard
Web-based dashboard aggregating factors that affect immunization to support planning and efforts to increase vaccine reach.
Global Immunization Insights Dashboard
Web-based dashboard aggregating factors that affect immunization to support planning and efforts to increase vaccine reach.
Services
Vaccine research and development services
End-to-end support for advancing vaccine candidates from preclinical work through early-phase clinical development, including translational immunology and preclinical models.
Clinical operations and trial management
Clinical trial design, site coordination, monitoring, and quality assurance for Phase 1–2 vaccine studies, including rapid deployment during outbreaks.
Applied epidemiology and programmatic evaluations
Field epidemiology, vaccine effectiveness studies, and program evaluations to inform immunization policy and implementation.
Global immunization analytics and dashboards
Development of dashboards and analytics that aggregate immunization-related indicators to inform program planning and track progress.
Partnership development and funding mobilization
Building multisector partnerships and securing public and philanthropic funding to support vaccine R&D and immunization initiatives.
Vaccine research and development services
End-to-end support for advancing vaccine candidates from preclinical work through early-phase clinical development, including translational immunology and preclinical models.
Clinical operations and trial management
Clinical trial design, site coordination, monitoring, and quality assurance for Phase 1–2 vaccine studies, including rapid deployment during outbreaks.
Applied epidemiology and programmatic evaluations
Field epidemiology, vaccine effectiveness studies, and program evaluations to inform immunization policy and implementation.
Global immunization analytics and dashboards
Development of dashboards and analytics that aggregate immunization-related indicators to inform program planning and track progress.
Partnership development and funding mobilization
Building multisector partnerships and securing public and philanthropic funding to support vaccine R&D and immunization initiatives.
Expertise Areas
- Vaccine development and translational immunology
- Clinical trial management and clinical operations
- Chemistry, Manufacturing and Controls (CMC) program leadership
- Regulatory strategy and submissions (FDA/EMA and novel pathways)
Key Technologies
- Recombinant protein vaccine platforms
- Adenoviral vector vaccine platforms
- Subunit and microbial vaccine platforms
- Animal models for filovirus and infectious disease research